找不到产品?留下需求帮您找
一键询价UPCISCC090 人舌头鳞癌细胞 QCH766
一周
3500¥
KNS62 人肺支气管鳞状细胞癌 QCH767
一周
3500¥
HCC95 人肺腺癌细胞 QCH768
一周
3500¥
HARA 人肺腺癌细胞 QCH769
一周
3500¥
EPLC272H 人肺腺癌细胞 QCH770
一周
4000¥
NCI-H810 人非小细胞肺癌细胞 QCH771
一周
5000¥
HBL-1 人弥漫性大B细胞淋巴瘤 QCH772
一周
1800¥
FTC238 人滤泡状甲状腺癌细胞,肺转移 XY-H773
一周
3500¥
SNU-719 人胃癌细胞 QCH774
一周
3500¥
BT549+GFP+LUC 人乳腺癌细胞 QCH766GL
钦诚生物 | 一周
4500¥
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:Nitazoxanide 产品别名:见爱必信官网 英文别名:Nitazoxanide 靶点:Antiparasitic CAS:55981-09-4 纯度:>98% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder); in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months. 描述: Nitazoxanide (Alinia, Annita) is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent. (IC50 for canine influenza virus ranges from 0.17 to 0.21 μM) The anti- protozoal activity of nitazoxanide is believed to be due to interference with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme dependent electron transfer reaction which is essential to anaerobic energy metabolism. It has also been shown to have activity against influenza A virus. Nitazoxanide and tizoxanide inhibited virus replication of all canine influenza virus with 50% and 90% inhibitory concentrations ranging from 0.17 to 0.21 μM and from 0.60 to 0.76 μM, respectively. 溶解性:DMSO :58 mg/mL (188.8 mM) 体外研究: Nitazoxanide reduces parasite growth in cell culture by more than 90% with little evidence of drug-associated cytotoxicity. Nitazoxanide is a new thiazolide antiparasitic agent that shows excellent in vitro activity against a wide variety of protozoa and helminths. Nitazoxanide and its metabolite tizoxanide are more active in vitro than metronidazole against G. intestinalis, E. histolytica and T. vaginalis. Nitazoxanide exhibits potent inhibition of both HBV and HCV replication. Nitazoxanide potentiates the effect of subsequent treatment with Nitazoxanide plus IFN, but not Nitazoxanide plus 2'CmeC, in HCV replicon-containing cells. Nitazoxanide induces reductions in several HBV proteins (HBsAg, HBeAg, HBcAg) produced by 2.2.15 cells, but does not affect HBV RNA transcription. Nitazoxanide exhibits IC50, and IC90 values of 0.017 and 0.776 mg/mL respectively, against E. histolytica, 0.004 and 0.067 mg/mL against G. intestinalis, and 0.034 and 2.046 mg/mL against T. vaginalis. Nitazoxanide is more toxic than metronidazole and albendazole against E. histolytica. 体内研究:Nitazoxanide is partially effective at reducing the parasite burden in a gnotobiotic piglet diarrhea model when given orally for 11 days at 250 mg/kg/day but not at 125 mg/kg/day. Nitazoxanide induces a drug-related diarrhea in piglets that might have influenced its therapeutic efficacy.
产品信息订购:
|